Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
WuXi Biologics (Cayman) Inc. (Stock Code: 2269.HK) is a premier, globally recognized Contract Research, Development, and Manufacturing Organization (CRDMO). The company provides comprehensive, integrated, end-to-end solutions for biologics, empowering clients worldwide to discover, develop, and manufacture innovative biologic drugs from initial concept through to commercial production. Their services span the entire biologics lifecycle, including drug discovery, development, clinical and commercial manufacturing, and regulatory support, leveraging cutting-edge technologies and state-of-the-art facilities.
Serves as a primary operational and strategic hub, overseeing global R&D initiatives, manufacturing operations, and corporate functions. It's central to the company's extensive network in China.
Features advanced R&D laboratories, pilot plants, and large-scale cGMP manufacturing facilities equipped with cutting-edge single-use bioreactor technology. Designed to foster innovation and collaboration.
A dynamic, science-driven environment emphasizing innovation, quality, speed, and customer-centricity. Employees often experience a fast-paced culture focused on solving complex challenges in biopharmaceutical development.
The Wuxi headquarters and associated facilities represent the company's strong foundation in China and its commitment to providing world-class biologics services. It's a critical node in their global manufacturing and R&D network.
WuXi Biologics operates a robust global network of research, development, and manufacturing sites across China, the United States, Ireland, Germany, and Singapore. This expansive footprint enables the company to provide comprehensive, end-to-end CRDMO services globally. Functions supported include early-stage drug discovery, antibody and protein engineering, cell line development, process development, analytical testing, and cGMP manufacturing of biologics for preclinical, clinical, and commercial supply, along with fill-finish capabilities and regulatory support.
No. 108, Meiliang Road, Mashan, Wuxi City, Jiangsu Province, 214092
Wuxi
Jiangsu Province
China
Address: Mullagharlin Road, Dundalk, Co. Louth, A91 P925, Ireland
To serve European and global clients with local, high-quality manufacturing capabilities, ensuring supply chain diversification and faster access to the European market.
Address: 373 Plantation Street (general area of the Biomanufacturing Center), Worcester, MA 01605, USA
To bolster WuXi Biologics' presence in the U.S. biotech hub, offering robust local manufacturing solutions and reducing transcontinental supply chain complexities for North American clients.
Address: Aprather Weg 18a, 42113 Wuppertal, Germany (facility previously part of Bayer)
To provide integrated drug product solutions within Europe, complementing its drug substance manufacturing network and streamlining the path from development to market for European clients.
Address: 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, China
Leverages Shanghai's position as a major biotech and innovation hub in China to serve both domestic and international clients, attract top talent, and drive technological advancements.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, WuXi Biologics' leadership includes:
WuXi Biologics has been backed by several prominent investors over the years, including:
WuXi Biologics has maintained a largely stable senior executive team focused on global expansion and operational excellence. Notable changes typically involve strategic appointments to bolster specific global functions or planned transitions for long-serving executives. Specific numbers reflect publicly announced major changes at the top executive/SVP level.
Discover the tools WuXi Biologics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
WuXi Biologics typically utilizes common corporate email address formats. The most prevalent formats are likely based on combinations of an employee's first name and last name, followed by the '@wuxibiologics.com' domain.
[first].[last]@wuxibiologics.com or [first_initial][last]@wuxibiologics.com
Format
jane.doe@wuxibiologics.com
Example
80%
Success rate
WuXi Biologics Official Website • May 8, 2024
WuXi Biologics' advanced manufacturing facility in Dundalk, Ireland, was recognized with several industry awards, highlighting its operational excellence, innovative 'Factory of the Future' design, and strong commitment to sustainable practices....more
WuXi Biologics Investor Relations • March 19, 2024
WuXi Biologics reported strong financial performance for the fiscal year 2023, driven by continued global demand for its integrated CRDMO services and successful execution of its 'Follow and Win the Molecule' strategy. The company highlighted significant growth in its project pipeline and expanded manufacturing capacities....more
WuXi Biologics Official Website • December 20, 2023
WuXi Biologics announced a significant licensing agreement with GSK, granting GSK access to WuXi Biologics’ proprietary technology platforms for the development and commercialization of up to four novel bi-specific and multi-specific T cell engaging antibodies....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including WuXi Biologics, are just a search away.